Anika Therapeutics, Inc. (FRA:AKP)

Anika Therapeutics Statistics

Total Valuation

FRA:AKP has a market cap or net worth of EUR 121.07 million. The enterprise value is 92.27 million.

Market Cap	121.07M
Enterprise Value	92.27M

Important Dates

The next estimated earnings date is Monday, March 9, 2026.

Earnings Date	Mar 9, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	14.42M
Shares Outstanding	n/a
Shares Change (YoY)	-2.20%
Shares Change (QoQ)	-0.68%
Owned by Insiders (%)	4.05%
Owned by Institutions (%)	64.29%
Float	10.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.26
PB Ratio	0.97
P/TBV Ratio	1.04
P/FCF Ratio	219.22
P/OCF Ratio	17.47
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.28
EV / Sales	0.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	167.07

Financial Position

The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.17.

Current Ratio	5.32
Quick Ratio	4.20
Debt / Equity	0.17
Debt / EBITDA	108.08
Debt / FCF	37.82
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -8.73% and return on invested capital (ROIC) is -3.89%.

Return on Equity (ROE)	-8.73%
Return on Assets (ROA)	-3.50%
Return on Invested Capital (ROIC)	-3.89%
Return on Capital Employed (ROCE)	-6.92%
Revenue Per Employee	333,835
Profits Per Employee	-97,769
Employee Count	288
Asset Turnover	0.54
Inventory Turnover	1.80

Taxes

In the past 12 months, FRA:AKP has paid 3.61 million in taxes.

Income Tax	3.61M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-48.47%
50-Day Moving Average	8.16
200-Day Moving Average	10.12
Relative Strength Index (RSI)	51.13
Average Volume (20 Days)	2

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.77

Income Statement

In the last 12 months, FRA:AKP had revenue of EUR 96.14 million and -28.16 million in losses. Loss per share was -1.95.

Revenue	96.14M
Gross Profit	53.15M
Operating Income	-10.05M
Pretax Income	-8.55M
Net Income	-28.16M
EBITDA	-3.13M
EBIT	-10.05M
Loss Per Share	-1.95

Balance Sheet

The company has 49.42 million in cash and 20.89 million in debt, giving a net cash position of 28.54 million.

Cash & Cash Equivalents	49.42M
Total Debt	20.89M
Net Cash	28.54M
Net Cash Per Share	n/a
Equity (Book Value)	125.12M
Book Value Per Share	8.68
Working Capital	70.32M

Cash Flow

In the last 12 months, operating cash flow was 6.93 million and capital expenditures -6.38 million, giving a free cash flow of 552,290.

Operating Cash Flow	6.93M
Capital Expenditures	-6.38M
Free Cash Flow	552,290
FCF Per Share	n/a

Margins

Gross margin is 55.28%, with operating and profit margins of -10.46% and -29.29%.

Gross Margin	55.28%
Operating Margin	-10.46%
Pretax Margin	-8.89%
Profit Margin	-29.29%
EBITDA Margin	-3.25%
EBIT Margin	-10.46%
FCF Margin	0.57%

Dividends & Yields

FRA:AKP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.20%
Shareholder Yield	2.20%
Earnings Yield	-23.26%
FCF Yield	0.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:AKP has an Altman Z-Score of 4.35 and a Piotroski F-Score of 3.

Altman Z-Score	4.35
Piotroski F-Score	3